Steven F. Casey, a partner in the firm's Business & Commercial Litigation Practice Group in the Birmingham office, was quoted in an article published by Law360 on April 8, 2015. The article titled, "Zoloft Plaintiffs Face High Stakes In First Birth Defect Trials," discusses the beginning of trials in the litigation against Pfizer Inc. over the alleged birth defect risks of the antidepressant, Zoloft. When asked about the case, Mr. Casey stated it is often difficult for "plaintiff expert witnesses to link the ingestion of the drug to link to the alleged injury." The full article may be found on Law360.com